Genmab A/S Income Statement

Income Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 334.45M558.04M1174.60M-142.96M-346.89M-200.64M-1438.56M
Gross Profit 334.45M558.04M1174.60M-142.96M-346.89M-200.64M-1438.56M
Operating items
Research & Development -158.22M-248.13M-364.43M
Share-based Compensation (IS) 24.16M
Selling, General & Administrative -23.66M-35.57M-76.79M
Operating Expenses -181.88M-283.70M-441.21M
Operating Income 274.34M733.38M
EBIT 177.01M274.34M733.38M
Non-operating items
Interest & Investment Income 26.87M23.71M133.48M-316.70M-183.09M-420.44M
Net income details
EBT 178.23M297.32M685.87M
Tax Provisions 15.48M72.07M133.13M113.79M150.26M
Profit After Tax 162.75M225.25M552.74M
Income from Continuing Operations 162.75M225.25M552.74M
Consolidated Net Income 162.75M225.25M552.74M
Income towards Parent Company 162.75M225.25M552.74M
Net Income towards Common Stockholders 162.75M225.25M552.74M
Additional items
EPS (Basic) 0.00M0.00M0.00M
EPS (Weighted Average and Diluted) 0.00M0.00M0.00M
Shares Outstanding (Weighted Average) 64.30M64.30M65.07M65.62M65.83M66.07M66.18M
EBITDA 163.85M225.88M277.07M
Tax Rate 8.68%24.24%19.41%